STSN (Stemsation International) Interest Coverage: N/A (As of Sep. 2011)


What is Stemsation International Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Stemsation International's Operating Income for the three months ended in Sep. 2011 was $-0.07 Mil. Stemsation International's Interest Expense for the three months ended in Sep. 2011 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Stemsation International's Interest Coverage or its related term are showing as below:


STSN's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.78
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Stemsation International  (OTCPK:STSN) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Stemsation International Interest Coverage Related Terms


Stemsation International Interest Coverage Historical Data

* Premium members only.

The historical data trend for Stemsation International's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Stemsation International Interest Coverage Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Interest Coverage
N/A No Debt 0.00 No Debt N/A

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

STSN vs MAMP, LODE: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Stemsation International's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemsation International Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemsation International's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Stemsation International's Interest Coverage falls into.



Stemsation International Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Stemsation International's Interest Coverage for the fiscal year that ended in Dec. 2010 is calculated as

Here, for the fiscal year that ended in Dec. 2010, Stemsation International's Interest Expense was $0.00 Mil. Its Operating Income was $-0.13 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.30 Mil.

GuruFocus does not calculate Stemsation International's interest coverage with the available data.

Stemsation International's Interest Coverage for the quarter that ended in Sep. 2011 is calculated as

Here, for the three months ended in Sep. 2011, Stemsation International's Interest Expense was $0.00 Mil. Its Operating Income was $-0.07 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.35 Mil.

GuruFocus does not calculate Stemsation International's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.